Ray Tabibiazar, MD is Managing Partner at Genesis BioCapital, an operator lead company-creation venture capital fund focused on building and financing innovative biotechnology companies. A physician-scientist, entrepreneur, and investor, he specializes in translating cutting-edge biology into capital-efficient therapeutics and platform companies.
Dr. Tabibiazar has founded and led multiple life-science ventures across genetic medicine, oncology, diagnostics, and synthetic biology. Genesis BioCapital portfolio companies are currently developing therapies across multiple fields, including genetic engineering, cancer, atrial fibrillation, depression, PTSD, preeclampsia and arthritis.
Dr. Tabibiazar trained in cardiology at Stanford, practiced clinical medicine for over a decade, and received his MD from Harvard Medical School and undergraduate at UCLA.